CLINICAL GUIDELINES Evidence-based Guidelines From ESPGHAN and NASPGHAN for Helicobacter pylori Infection in Children Sibylle Koletzko, yNicola L. Jones, zKaren J. Goodman, §Benjamin Gold, jjMarion Rowland, ô

First Page		Document Content
Date: 2014-08-20 03:31:19 Gastrointestinal cancer Gram-negative bacteria Proteobacteria Abdominal pain Helicobacter pylori Urea breath test Peptic ulcer Rapid urease test Dyspepsia Medicine Health Gastroenterology		CLINICAL GUIDELINES Evidence-based Guidelines From ESPGHAN and NASPGHAN for Helicobacter pylori Infection in Children Sibylle Koletzko, yNicola L. Jones, zKaren J. Goodman, §Benjamin Gold, jjMarion Rowland, ô Add to Reading List Source URL: www.espghan.org Download Document from Source Website File Size: 411,01 KB Share Document on Facebook

	ORIGINAL ARTICLE doi:j00271.x NATURAL TRANSFORMATION INCREASES THE RATE OF ADAPTATION IN THE HUMAN PATHOGEN HELICOBACTER PYLORI DocID: 1sDtT - View Document
	Press Release ImevaX secures EUR 7.5 million in Series A Financing to develop highly specific vaccine against Helicobacter pylori infections Munich (Germany), October 28, 2014: ImevaX GmbH, a specialist in vaccines agai DocID: 1rRrC - View Document
	ImmunoCard STAT!® HpSA® HD NEXT GENERATION, HIGH DEFINITION RAPID TEST FROM THE LEADER IN STOOL ANTIGEN TESTING DEFINITIVE ANSWERS, CONFIDENT RESULTS® DocID: 1rtI8 - View Document
	Press Release ImevaX welcomes KfW to investor syndicate in second closing of Series A financing Munich (Germany), March 02, 2015: ImevaX GmbH, a specialist in vaccines against pathogens of chronic infectious diseases, e DocID: 1rjwj - View Document
	JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG, GERMANY Research Centre for Infectious Diseases (ZINF) PhD STUDENT Position “Virulence factors and regulators required during infections with the food-borne pathogen Campyloba DocID: 1r4bs - View Document